ArticlePloS one2017

Reactive oxygen species modulator-1 (Romo1) predicts unfavorable prognosis in colorectal cancer patients.

Hong Jun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.